Abstract
Device closure of atrial septum defect was performed using an Amplatzer septal occluder in a 48-year-old patient with Marfan syndrome. Acute tamponade due to perforation was observed 2 months after catheter intervention. Careful consideration of the indication for device closure for atrium septal defect is necessary in patients with Marfan syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tateishi M, Tomizawa Y. Intravascular foreign bodies: danger of unretrieved fragmented medical devices. J Artif Organs. 2009;12:80–9.
Sawa Y, Tatsumi E, Funakubo A, Horiuchi T, Iwasaki K, Kishida A, Masuzawa T, Matsuda K, Myoui A, Nishimura M, Nishimura T, Tomizawa Y, Tomo T, Yamaoka T, Watanabe H. Journal of artificial organs 2009: the year in review. J Artif Organs. 2010;13:1–9.
Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42:388–94.
Yasukochi S. Current status of transcatheter closure of atrial septal defect. Respir Circ. 2009;57:1305–10 (in Japanese).
Oho S, Ishizawa A, Akagi T, Dodo H, Kato H. Transcatheter closure of atrial septal defects with the Amplatzer septal occluder: a Japanese clinical trial. Circ J. 2002;66:791–4.
Dhillon R, Josen M, Henein M, Redington A. Transcatheter closure of atrial septal defect preserves right ventricular function. Heart. 2002;87:461–5.
Zhu W, Neubauer H. Secondary residual shunt after atrial septal defect closure with an amplatzer occluder: surgical removal and evaluation of device biocompatibility after 7 years. Pediatr Cardiol. 2010;31:1107–10.
Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Cathet Cardiovasc Interv. 2004;63:496–502.
Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol. 2005;45:1213–8.
DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg. 2009;137:1334–41.
Sarris GE, Kirvassilis G, Zavaropoulos P, Belli E, Berggren H, Carrel T, Comas JV, Corno AF, Daenen W, Di Carlo D, Ebels T, Fragata J, Hamilton L, Hraska V, Jacobs J, Lazarov S, Mavroudis C, Metras D, Rubay J, Schreiber C, Stellin G. Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg. 2010;37:1285–90.
Loeffelbein F, Schlensak C, Dittrich S. Penetration of left and right atrial wall and aortic root by an Amplatzer atrial septal occluder in a nine year old boy with Marfan syndrome: case report. J Cardiothorac Surg. 2008;3:25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tateishi, M., Hiramatsu, T., Tomizawa, Y. et al. Cardiac tamponade due to perforation by an Amplatzer atrial septal occluder in a patient with Marfan syndrome. J Artif Organs 14, 261–263 (2011). https://doi.org/10.1007/s10047-011-0576-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-011-0576-6